Уноси

• Stroncium ranelat u lečenju osteoporoze (2004)

  N. Prodanović, Stroncium ranelat u lečenju osteoporoze, Balneoclimatologia , pp. 113 - 118, 2004

• Klinička primjena markera koštanog metabolizma u osteoporozi (2004)

  N. Prodanović, B. Božić, Klinička primjena markera koštanog metabolizma u osteoporozi, Balneoclimatologia , pp. 99 - 112, 2004

• Procena uspešnosti antiresorptivne terapije osteoporoze merene veličinom promena koštano specifične alkalne fosfataze (2004)

  N. Prodanović, B. Božić, I. Zgradić, Procena uspešnosti antiresorptivne terapije osteoporoze merene veličinom promena koštano specifične alkalne fosfataze, Balneoclimatologia , pp. 255 - 256, 2004

• The significance of helical peptides in the assessment of bone metabolism in active rheumatoid arthritis (2005)

  N. Prodanović, B. Božić, I. Zgradić, The significance of helical peptides in the assessment of bone metabolism in active rheumatoid arthritis, CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, pp. 1 - 2, 2005

• The Republic of Srpska Iodine Deficiency Survey 2006 (2008)

  A. Lolić, N. Prodanović, The Republic of Srpska Iodine Deficiency Survey 2006, HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, Vol. 7, No. 2, pp. 163 - 169, 2008

• Relationship Between High Circulating Adiponectin With Bone Mineral Density and Bone Metabolism in Elderly Males With Chronic Heart Failure (2010)

  G. Lončar, B. Božić, N. Prodanović, Z. Radojčić, N. Čvorović, S. Dimković, V. Popović, Relationship Between High Circulating Adiponectin With Bone Mineral Density and Bone Metabolism in Elderly Males With Chronic Heart Failure, JOURNAL OF CARDIAC FAILURE, Vol. 16, No. 4, pp. 301 - 307, 2010

• Relationship between RANKL and neuroendocrine activation in elderly males with heart failure (2010)

  G. Lončar, B. Božić, N. Čvorović, Z. Radojčić, S. Dimković, N. Marković Nikolić, N. Prodanović, Relationship between RANKL and neuroendocrine activation in elderly males with heart failure, ENDOCRINE, Vol. 37, No. 1, pp. 148 - 156, 2010

• SERUM RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KB LIGAND (RANKL) AS BIOMARKER OF CHRONIC HEART FAILURE IN ELDERLY MALES (2010)

  B. Božić, G. Lončar, N. Prodanović, V. Čvorović, SERUM RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KB LIGAND (RANKL) AS BIOMARKER OF CHRONIC HEART FAILURE IN ELDERLY MALES, OSTEOPOROSIS INTERNATIONAL, pp. 21 - 32, 2010

• Efficacy and Safety of Once Monthly Ibandronate Treatment in Patients with Reduced Bone Mineral Density - ESTHER Study (2010)

  N. Vujasinović Stupar, N. Milić, L. Petrović Lackov, N. Prodanović, M. Mijailović Ivković, Z. Grujić, Efficacy and Safety of Once Monthly Ibandronate Treatment in Patients with Reduced Bone Mineral Density - ESTHER Study, SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, Vol. 138, No. 1-2, pp. 56 - 61, 2010

• Parathyroid Hormone Response to Vitamin D Insufficiency in Elderly Males With Chronic Heart Failure (2011)

  B. Božić, G. Lončar, N. Prodanović, T. Lepić, Z. Radojčić, V. Čvorović, S. Dimković, B. Popović, Parathyroid Hormone Response to Vitamin D Insufficiency in Elderly Males With Chronic Heart Failure, Physiological research , pp. 155 - 163, 2011

• Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure (2011)

  G. Lončar, B. Božić, S. Dimković, N. Prodanović, Z. Radojčić, V. Čvorović, Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure, JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, pp. 78 - 85, 2011

• Relationship of reduced cerebral blood flow and heart failure severity in elderly males (2011)

  G. Lončar, B. Božić, S. Dimković, N. Prodanović, Z. Radojčić, V. Čvorović, Relationship of reduced cerebral blood flow and heart failure severity in elderly males, AGING MALE, pp. 59 - 65, 2011

• A potential cross-talk between fat and bone in patients with chronic heart failure (2011)

  G. Lončar, B. Božić, N. Prodanović, Z. Radojčić, N. Čvorović, S. Dimković, V. Popović, A potential cross-talk between fat and bone in patients with chronic heart failure, EUROPEAN HEART JOURNAL, pp. 32 - 609, 2011

• Digital clubbing as an unusual comlication of the secondary hyperparathyroidism associated atypical neutrophils: a case report (2012)

  N. Prodanović, Z. Špirić, G. Trninić, M. Erić, Digital clubbing as an unusual comlication of the secondary hyperparathyroidism associated atypical neutrophils: a case report, EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, pp. 98 - 102, 2012

• Association od adiponetic with peripheral muscle status in elderly patients with heart failure (2013)

  G. Lončar, B. Božić, S. Healing, N. Prodanović, V. Popović-Brkić, Association od adiponetic with peripheral muscle status in elderly patients with heart failure, EUROPEAN JOURNAL OF INTERNAL MEDICINE, pp. 10 - 10, 2013

• A randomised,double-blind,parallel-group study to dmostrate eqivalence in afficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis:The PLANETRA study (2013-05)

  D. Yoo, P. Hrycaj, P. Miranda, E. Ramiterre, M. Piotrowski, S. Shevchuk, V. Kovalenko, N. Prodanović, M. Abello-Banfi, S. Gutierrez-Ureña, L. Morales-Olazabal, M. Tee, R. Jimenez, O. Zamani, S. Lee, H. Kim, W. Park, U. Müller-Ladner, A randomised,double-blind,parallel-group study to dmostrate eqivalence in afficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis:The PLANETRA study, ANNALS OF THE RHEUMATIC DISEASES, pp. 10 - 10, May, 2013

• 1. Osteoporoza u inflamatornim bolestima creva (2013-05)

  N. Prodanović, 1. Osteoporoza u inflamatornim bolestima creva, STED Journal, Vol. 39, No. 1, pp. 149 - 156, May, 2013

• FRI0281 The Rate of Positive Conversion in the Quantiferon- TB Gold Test over 2 Years among Patients Treated with CT-P13 or Innovator Infliximab in the Extension Studies of Planetas and Planetra (2014)

  P. Wonung, D. Yoo, P. Hrycaj, N. Prodanović, S. Lee, FRI0281 The Rate of Positive Conversion in the Quantiferon- TB Gold Test over 2 Years among Patients Treated with CT-P13 or Innovator Infliximab in the Extension Studies of Planetas and Planetra, ANNALS OF THE RHEUMATIC DISEASES, pp. 10 - 10, 2014

• FRI0143 A radomized, double-blind, phase 3 study demonstrates clinical equivalence od CT-P13 to ifliximab when co-administered with methotrexate in patients with active rheumatoid arthritis (2014)

  D. Yoo, P. Hrycaj, P. Miranda, E. Piotrowski, S. Shevchuk, V. Kovalenko, N. Prodanović, M. Abello-Banfi, S. Gutierrez-Ureña, L. Morales-Olazabal, M. Tee, R. Jimenez, O. Zamani, S. Lee, H. Kim, W. Park, U. Müller-Ladner, FRI0143 A radomized, double-blind, phase 3 study demonstrates clinical equivalence od CT-P13 to ifliximab when co-administered with methotrexate in patients with active rheumatoid arthritis, ANNALS OF THE RHEUMATIC DISEASES, pp. 10 - 10, 2014

• BONE MARKERS IN MONITORING OF ANTIRESORPTIVE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS PATIENTS (2015)

  T. Đopalić, N. Prodanović, B. Božić, BONE MARKERS IN MONITORING OF ANTIRESORPTIVE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS PATIENTS, Acta medica Medianae, Vol. 54, No. 3, pp. 5 - 11, 2015